Dr. Stelios Papadopoulos is a Chairman at Eucrates Biomedical Acquisition Corp., a Chairman at Regulus Therapeutics, Inc., a Chairman at Biogen, Inc., a Chairman-Supervisory Board at Biogen GmbH, a Chairman & Treasurer at Fondation Santé, a Chairman at Exelixis, Inc. and an Adjunct Associate Professor at New York University. He is on the Board of Directors at Biogen Idec, Inc. (North Carolina), Diacrin, Inc. (Delaware), National Marrow Donor Program and The BioExec Institute, Inc. Dr. Papadopoulos was previously employed as an Independent Director by BG Medicine, Inc., a Founder by Cellzome Ltd., a Vice Chairman by Cowen & Co. LLC, a Chairman by Anadys Pharmaceuticals, Inc., a President by Instrumentation Laboratory Co., a Chairman by PaineWebber Development Corp., an Investment Banker by PaineWebber, Inc., a Chairman by Cellzome, Inc., and a Vice President-Equity Research Department by Drexel Burnham Lambert, Inc. He also served on the board at GenVec, Inc., SGX Pharmaceuticals, Inc., Biogen Idec New Ventures, Inc., Joule Unlimited Technologies, Inc. and Neuronyx, Inc. He received his graduate degree from New York University, an MBA from New York University and a doctorate degree from New York University.